APA (7th ed.) Citation

Schmidli, H., Peng, B., Riviere, G., Capdeville, R., Hensley, M., Gathmann, I., . . . Racine-Poon, A. (2005). Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: Results of a phase III study. British Journal of Clinical Pharmacology, 60(1), 35. https://doi.org/10.1111/j.1365-2125.2005.02372.x

Chicago Style (17th ed.) Citation

Schmidli, H., B. Peng, G-J Riviere, R. Capdeville, M. Hensley, I. Gathmann, A. E. Bolton, and A. Racine-Poon. "Population Pharmacokinetics of Imatinib Mesylate in Patients with Chronic-phase Chronic Myeloid Leukaemia: Results of a Phase III Study." British Journal of Clinical Pharmacology 60, no. 1 (2005): 35. https://doi.org/10.1111/j.1365-2125.2005.02372.x.

MLA (9th ed.) Citation

Schmidli, H., et al. "Population Pharmacokinetics of Imatinib Mesylate in Patients with Chronic-phase Chronic Myeloid Leukaemia: Results of a Phase III Study." British Journal of Clinical Pharmacology, vol. 60, no. 1, 2005, p. 35, https://doi.org/10.1111/j.1365-2125.2005.02372.x.